Register

Company Profile

Sourcing Inquiry Logo Jennerex, Inc.

Jennerex, Inc.

Regions
North America
Countries
United States
Size
n.e.
Specialty
Biopharmaceuticals
Service category
Formulation development and drug delivery
Content posted and uploaded by users. Want to add your company?
Your company? Get access to this profile.

Summary

Jennerex, Inc. is a private, clinical-stage biotherapeutics company focused on the design, development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for cancer. Our lead product JX-594 is currently in a randomized Phase 2b clinical trial for hepatocellular carcinoma (HCC) and Phase 1/2 clinical development for colorectal cancer (CRC). A 30-patient, randomized, controlled Phase 2 clinical trial of JX-594 in advanced HCC showed a statistically significant, dose-dependent increase in overall survival for high-dose JX-594 versus low-dose JX-594. Clinical trials of JX-594 using both intratumoral and intravenous administration are being conducted in multiple tumor types.

Stories

See all

Pictures of this company

You might also be interested in

Sourcing this company's services?

Send inquiry anonymously »

Or add this Company to
Sourcing cart